Aaron I. Davis, Director, 10% Owner at Odonate Therapeutics, Inc. (ODT), bought 400,000 shares at $16.90 ($6.9M) on 2020-12-28, disclosed to the SEC on 2020-12-30.
Open-market purchase of $6.9M ODT by Director, 10% Owner. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade B.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.90 | 75,000 | $1.3M | 18.5% |
| 2 | $17.11 | 225,000 | $3.8M | 56.1% |
| 3 | $17.46 | 100,000 | $1.7M | 25.4% |
| Total | $17.16 avg | 400,000 | $6.9M | 100% |
| Filing → |
| TYRA | SELL | 2023-02-13 | $4.4M | — | Filing → |
| RAIN | BUY | 2022-11-08 | $11.3M | — | Filing → |
| ITOS | SELL | 2022-05-11 | $20.2M | — | Filing → |